Funding opportunity: Neonatal Abstinence Syndrome State Surveillance Project

Funding opportunity: Neonatal Abstinence Syndrome State Surveillance Project


The March of Dimes (MOD), in collaboration with the Centers for Disease Control and Prevention (CDC), will award up to six grants for the “Building on Existing Infrastructure of Population-based Birth Defects Surveillance Systems to Estimate the Incidence of Neonatal Abstinence Syndrome (NAS)” project. Awardees will conduct active (or passive case-finding with case confirmation), population-based surveillance for infants with NAS over a one year period and link cases to vital records and hospital discharge data. The main goal of the project will be to obtain state-level, population-based estimates of NAS incidence, with a secondary goal to describe health service utilization and outcomes among infants with NAS.


This is a one-year grant. A Letter of Intent (LOI) is required to apply. Additional details and deadlines are outlined below and in the Request for Proposals.


A bidders’ conference call is scheduled for January 19, 2017 from 2:00 – 3:00 pm EST.

To participate in this call, register here or copy and paste  in your browser. 


Contact with any questions.


Duration of award:                                1 year

Type of funding:                                   Federal, CFDA #93.424

Total funding available:                        Approximately $230,000

Number of awards:                               1-6 awards ranging from approximately

$40,000-$70,000 per awardee

Bidders’ conference call:                      January 19, 2017, 2:00 – 3:00PM EST

Letter of intent (LOI) due (required):     January 30, 2017 by 11:59PM EST

Application due:                                   March 6, 2017 by 11:59PM EST

Anticipated award date:                        May 1, 2017


This project is funded using federal funds from the Department of Health and Human Services, Centers for Disease Control and Prevention. The project is administrated by the March of Dimes Foundation and is subject to all applicable federal requirements.


Recent Stories
Press Release: Advances in 3-D Printing Launch a Promising Future for Birth Defects Treatments

Grant Opportunity: Advancing Actionable Alternatives to Vertebrate Animal Testing for Chemical Safety Assessment

Webinar: The Challenge of Substance-Exposed Newborns, September 27 at 11 am ET